<DOC>
	<DOCNO>NCT00003325</DOCNO>
	<brief_summary>RATIONALE : Lymphatic mapping may improve ability detect cancer vulva . PURPOSE : This phase III trial study well lymphatic mapping work treat patient stage I stage II cancer vulva .</brief_summary>
	<brief_title>Lymphatic Mapping Treating Patients With Stage I Stage II Cancer Vulva</brief_title>
	<detailed_description>OBJECTIVES : - Determine negative predictive value negative sentinel lymph node patient invasive squamous cell carcinoma vulva . - Determine location sentinel node patient . OUTLINE : Patients receive injection ( ) isosulfan blue dermis junction tumor normal vulvar skin . Once afferent lymphatic channel sentinel node identify , patient undergo unilateral bilateral inguinal-femoral lymphadenectomy follow resection primary tumor adequate margin . Preoperative lymphoscintigraphy also perform . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter recurrence . PROJECTED ACCRUAL : A total 40-630 patient accrue study within 2-6 year .</detailed_description>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm invasive squamous cell carcinoma vulva great 1 mm thickness measure near rete peg Tumor size must 26 cm No recurrent disease Prior excision primary disease history carcinoma situ vulva allow No tumor extend urethra , anus , vagina , rectum , bladder No grossly suspicious inflame groin node physical exam No grossly infect primary tumor PATIENT CHARACTERISTICS : Age : Any age Performance status : GOG 03 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No invasive malignancy within past 5 year except nonmelanomatous skin cancer No know hypersensitivity phenylethane compound PRIOR CONCURRENT THERAPY : No prior cancer therapy contraindicate therapy study Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics No prior groin dissection</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>stage I vulvar cancer</keyword>
	<keyword>stage II vulvar cancer</keyword>
	<keyword>squamous cell carcinoma vulva</keyword>
</DOC>